Kåre Schultz skuffer en smule med Teva i andet kvartal
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Kare Schultz | C-SPAN.org
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the
Sådan har Teva-aktien udviklet sig under Kåre Schultz
End Of Schultz Era Looms For Teva :: Generics Bulletin
Dansk topchef trukket i retten: Kåre Schultz og Teva anklages for at skjule skandalesager
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva CEO steps down, replacement found — MedWatch
Teva CEO: We have to launch new products - Globes
Teva denies outgoing CEO board role — MedWatch
Teva Appoints Lundbeck's Schultz as CEO | Ctech
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
Teva Punished After Weak Outlook (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Serial Problem Solver
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Kåre Schultz får stor lønstigning i Teva
Kåre Schultz vil stoppe i Teva efter 2023: “Det bliver nok mere bestyrelsesarbejde”
Business-update: Kåre Schultz forgyldt med lønforhøjelse på op til 26 mio. kroner
